Cable Hill Partners’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

Cable Hill Partners’s Portfolio TPI Stock Details TPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-57,000	Closed	-$2K	–	992
2016 Q2	$2K	Hold	57,000	–	–	﹤0.01%	654
2016 Q1	$8K	Hold	57,000	–	–	0.01%	404
2015 Q4	$10K	Hold	57,000	–	–	0.01%	362
2015 Q3	$12K	Hold	57,000	–	–	0.01%	344
2015 Q2	$27K	Hold	57,000	–	–	0.02%	242
2015 Q1	$26K	Hold	57,000	–	–	0.02%	232
2014 Q4	$42K	Buy	+57,000	New	+$31.2K	0.04%	166

Other funds holding TPI

PAM

Pope Asset Management Memphis, Tennessee $162M AUM

Cable Hill Partners's TPI Position: Q3 2016 in Review

Cable Hill Partners sold out of TIANYIN PHARMACEUTICAL (TPI) in Q3 2016, closing a stake of 57,000 shares — an estimated $2K sold.

Cable Hill Partners first reported a position in TPI in Q4 2014 and held it in 7 quarters. The position peaked at $42K in Q4 2014. 1 fund tracked by Wall St. Rank holds TPI as of Q3 2016.

Cable Hill Partners reported no remaining TIANYIN PHARMACEUTICAL position as of Q3 2016 after selling out during the quarter.
Cable Hill Partners sold 57,000 TIANYIN PHARMACEUTICAL shares in Q3 2016, an estimated $2K.
Cable Hill Partners first reported a position in TIANYIN PHARMACEUTICAL in Q4 2014 and held it in 7 quarters.
Cable Hill Partners's TIANYIN PHARMACEUTICAL position peaked at $42K in Q4 2014.
1 fund tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q3 2016.

Based on Cable Hill Partners's 13F filing for Q3 2016, filed 16 Nov 2016.